EUVIMEDEUVIMED entdecken
Crossref

Safety and Efficacy of Intra‐Arterial Chemotherapy Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Head and Neck Squamous Cell Carcinoma

Chao Yang iD, Jin-Long Zhang, Zheng Li, Xi-Hong Liang, Hong-Wei Zhao

Head & Neck · 2025

DOI: 10.1002/hed.28121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, 2025. Verfasst von Chao Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Beijing Tongren Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate the efficacy and safety of local intra‐arterial chemotherapy combined with immune checkpoint inhibitors in the treatment of unresectable head and neck squamous cell carcinoma (HNSCC).

Methods

A retrospective analysis was conducted on the clinical data of eight patients diagnosed with unresectable HNSCC at our hospital from January to December 2023. All patients were diagnosed by pathological diagnosis and treated with intra‐arterial chemotherapy combined with immune checkpoint inhibitors. The overall response rate (ORR), progression‐free survival (PFS), overall survival (OS), and adverse reactions were observed.

Results

The study cohort consisted of seven men and one woman, with a median age of 58.4 ± 13.1 years. Five patients were at stage IVA, one at stage IVB, and two at stage IVC. One patient was lost to follow‐up, and among the 7 patients with complete data, the ORR was 85.7%. The median PFS and OS in the overall population were not achieved, and the patient tolerated the treatment well with no significant adverse effects.

Conclusion

Local intra‐arterial chemotherapy combined with immune checkpoint inhibitors is an important future exploration direction for the treatment of unresectable HNSCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsSquamous Cell Carcinoma of Head and NeckHead and Neck NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsHumansMaleMiddle AgedFemaleRetrospective StudiesInfusions, Intra-ArterialAgedTreatment OutcomeAdultNeoplasm StagingProgression-Free Survival

Stichwörter der Autor:innen

efficacy and safetyhead and neck squamous cell carcinomaimmunotherapyintra‐arterial chemotherapy

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Radiology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.

ORCID-Profile: Chao Yang

Zitieren

APA

Yang, C., Zhang, J. L., Li, Z., Liang, X. H., & Zhao, H. W. (2025). Safety and Efficacy of Intra‐Arterial Chemotherapy Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Head and Neck Squamous Cell Carcinoma. Head & Neck. https://doi.org/10.1002/hed.28121

Vancouver

Yang C, Zhang JL, Li Z, Liang XH, Zhao HW. Safety and Efficacy of Intra‐Arterial Chemotherapy Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Head and Neck Squamous Cell Carcinoma. Head & Neck. 2025. doi:10.1002/hed.28121

BibTeX
@article{Yang2025,
  author = {Yang, Chao and Zhang, Jin-Long and Li, Zheng and Liang, Xi-Hong and Zhao, Hong-Wei},
  title = {Safety and Efficacy of Intra‐Arterial Chemotherapy Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Head and Neck Squamous Cell Carcinoma},
  journal = {Head & Neck},
  year = {2025},
  doi = {10.1002/hed.28121}
}
Kostenlos starten →